Search for: "PFIZER INC, A corporation" Results 81 - 100 of 338
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2014, 9:52 am by David C. Scileppi
Grace & Co., Senior Vice President – Corporate Governance and Secretary of CA, Inc., and Managing Director, Secretary and Associate General Counsel of FGIC Corporation/Financial Guaranty Insurance Company. [read post]
31 Jul 2014, 12:00 am
Rosenzweig During the past year, major corporations, including Chiquita Brands International Inc., Mallinckrodt Pharmaceuticals, Abbvie Inc., Applied Materials Inc., and Medtronic Inc., have announced or completed such deals. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
15 Jul 2014, 5:27 am by Nietzer
Jay Martin, Chief Compliance Officer (CCO) at BakerHughes Inc. suggests an approach that reviews key risk factors to move forward. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Milliken & Company Northrop Grumman Corporation Novartis Patent Café.com, Inc. [read post]
22 Jun 2014, 9:01 pm by Ronald D. Rotunda
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
13 Apr 2014, 8:59 am by Barry Sookman
Pfizer Canada Inc., [2012] 3 S.C.R. 625 The patent system is based on a “bargain”, or quid pro quo:  the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge. [read post]
22 Jan 2014, 9:02 am by Joe Consumer
” A settlement in a case brought by Pfizer Inc. may have averted the year’s best chance for a billion-dollar verdict. [read post]
9 Dec 2013, 7:01 am by Lyle Denniston
In the Pfizer case — Pfizer Inc. v. [read post]
25 Oct 2013, 1:03 pm
• In one of the largest qui tam awards in history, a former employee of pharmaceutical giant Pfizer, Inc. brought a qui tam lawsuit against the drug manufacturer, alleging the company was engaged in off-label marketing of one of its drugs for uses that were considered unsafe and dangerous. [read post]
19 Sep 2013, 5:48 am by Kelly Phillips Erb
Tax Court (Tax Court No. 015675-11 BMC Software Inc. v Commissioner of Internal Revenue). [read post]
18 Sep 2013, 7:28 am
 The IPKat has stumbled across a decision earlier this year from the Federal Court, Canada, in Pfizer Canada Inc. v Pharmascience Inc. 2013 FC 120, dating back to 4 February. [read post]
31 Jul 2013, 8:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]